Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stavros Apostolakis

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Expert Opinion on Pharmacotherapy|January 9, 2013
Flecainide acetate for the treatment of atrial and ventricular arrhythmiasStavros Apostolakis, Michael Oeff, Ulrich Tebbe, et al.
BMJ Clinical Evidence|November 15, 2011
Atrial fibrillation (chronic)Deirdre A Lane, Stavros Apostolakis, Christopher J Boos, et al.
Journal of the American College of Cardiology|December 19, 2012
Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patientsStavros Apostolakis, Deirdre A Lane, Yutao Guo, et al.
European Heart Journal|August 23, 2013
Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trialStavros Apostolakis, Yuotao Guo, Deirdre A Lane, et al.
Journal of the American College of Cardiology|August 4, 2012
Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) studyStavros Apostolakis, Deirdre A Lane, Yutao Guo, et al.
Journal of the American College of Cardiology|January 26, 2013
Reply: To PMID 22858389Stavros Apostolakis, Deirdre A Lane, Yutao Guo, et al.
Journal of Thrombosis and Thrombolysis|May 1, 2009
Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary interventionKonstantina Vogiatzi, Stavros Apostolakis, Vassilis Voudris, et al.
Journal of Clinical Immunology|April 4, 2008
Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspectiveKonstantina Vogiatzi, Stavros Apostolakis, Vassilios Voudris, et al.
Thrombosis Research|May 25, 2007
CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulatorsStavros Apostolakis, Elias Krambovitis, Zaharenia Vlata, et al.
Advances in Cancer Research|April 17, 2007
Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implicationsStavroula Baritaki, Stavros Apostolakis, Peggy Kanellou, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Expert Opinion on Pharmacotherapy|January 9, 2013
Flecainide acetate for the treatment of atrial and ventricular arrhythmiasStavros Apostolakis, Michael Oeff, Ulrich Tebbe, et al.
BMJ Clinical Evidence|November 15, 2011
Atrial fibrillation (chronic)Deirdre A Lane, Stavros Apostolakis, Christopher J Boos, et al.
Journal of the American College of Cardiology|December 19, 2012
Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patientsStavros Apostolakis, Deirdre A Lane, Yutao Guo, et al.
European Heart Journal|August 23, 2013
Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trialStavros Apostolakis, Yuotao Guo, Deirdre A Lane, et al.
Journal of the American College of Cardiology|August 4, 2012
Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) studyStavros Apostolakis, Deirdre A Lane, Yutao Guo, et al.
Journal of the American College of Cardiology|January 26, 2013
Reply: To PMID 22858389Stavros Apostolakis, Deirdre A Lane, Yutao Guo, et al.
Journal of Thrombosis and Thrombolysis|May 1, 2009
Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary interventionKonstantina Vogiatzi, Stavros Apostolakis, Vassilis Voudris, et al.
Journal of Clinical Immunology|April 4, 2008
Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspectiveKonstantina Vogiatzi, Stavros Apostolakis, Vassilios Voudris, et al.
Thrombosis Research|May 25, 2007
CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulatorsStavros Apostolakis, Elias Krambovitis, Zaharenia Vlata, et al.
Advances in Cancer Research|April 17, 2007
Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implicationsStavroula Baritaki, Stavros Apostolakis, Peggy Kanellou, et al.
Pageof 9